Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide maps of chromatin state in human iPSC derived Cardiomyocytes with 2N and 4N DNA content.

ABSTRACT: Genome-wide maps of chromatin state in human iPSC derived Cardiomyocytes with 2N and 4N DNA content.

PROVIDER: PRJNA534525 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8952630.fastq.gz	Fastqsanger.gz
	SRR8952640.fastq.gz	Fastqsanger.gz
	SRR8952650.fastq.gz	Fastqsanger.gz
	SRR8952660.fastq.gz	Fastqsanger.gz
	SRR8952670.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Genome-wide maps of chromatin state in human iPSC derived Cardiomyocytes with 2N and 4N DNA content.

Project description:ChIP-seq was performed for seven marks (H3K4me1, H3K4me2, H3K4me3, H3K27ac, H3K27me3, H3K9me3, and H3K36me3) with Inputs on iPSC derived Cardiomyocytes with either 2N or 4N DNA content (3 replicates). Replicates were combined and put into the ChromImpute and ChromHMM pipelines (Ernst and Kellis, 2015), and a 25 state chromatin profilefor each was developed.

2021-05-06 | GSE130285 | GEO

Genome-wide maps of chromatin state in human iPSC derived Cardiomyocytes with 2N and 4N DNA content.

Project description:Genome-wide maps of chromatin state in human iPSC derived Cardiomyocytes with 2N and 4N DNA content.

| PRJNA534525 | ENA

Gordonia sp. 4N strain:4N | isolate:4N

Project description:Gordonia sp. 4N strain:4N | isolate:4N Genome sequencing and assembly

| PRJNA898132 | ENA

Proteomics analysis of 2n+x aneuploid yeast

Project description:We generated forty 2n+x aneuploid yeast strains and qualify the proteomes in nine of them using SILAC.

2019-05-23 | PXD007157 | Pride

Identification of cardiomyocyte-derived microvesicles content.

Project description:Investigation of content of microvesicles exocytosed by cardiomyocytes. The aims of the study were to identify DNA and RNA content in microvesicles from cardiomyocytes. DNA and RNA were purified from microveicles from cultured cardiomyocytes. Illumina microarrays were used to detect DNA and mRNA molecules and identify them.

2011-11-01 | GSE21707 | GEO

Expression data from patient iPSC and iPSC-derived cardiomyocytes

Project description:Dilated cardiomyopathy (DCM) is the leading cause of heart failure and transplantation worldwide. We used iPSCs to model this disease and compared gene expression change before and after gene therapy of cardiomyocytes derived from DCM-specific iPSCs. We used microarrays to detail the global gene expression of patient specific iPSCs, iPSC-derived cardiomyocytes and its response to gene therapy. Skin fibroblasts and iPSCs derived from a family exhibiting familial dilated cardiomyopathy and H7 human ESCs were subjected to RNA extraction and hybridization on Affymetrix microarrays.Global gene expression pattern were compared and analyzed. Cardiomyocytes derived from iPSCs generated from this DCM family were treated with or without adenoriral Serca2a and subjected to RNA extraction and hybridization on Affymetrix microarrays. Global gene expression pattern were compared and analyzed.

2012-02-01 | E-GEOD-35108 | biostudies-arrayexpress

Bacillus cereus strain:4N

Project description:Bacillus cereus strain:4N Genome sequencing and assembly

| PRJNA815817 | ENA

Study of transcriptional content in exosomes derived from untreated and growth factor-treated cultured cardiomyocytes (HL-1)

Project description:Introduction: Exosomes are nano-sized extracellular vesicles, released from various cells, which can stimulate or repress responses in target cells. We have recently shown that cultured cardiomyocytes release exosomes and that they, in turn, are involved in facilitating events in target cells by alteration of gene expression. We investigated whether external stimuli of the cardiomyocyte might influence the released exosome characteristics. Material and Methods: Exosomes were isolated from media collected from cultured cardiomyocyte (HL-1) cells with or without growth factor treatment (TGF-beta2 and PDGF-BB), with a series of differential centrifugations. The exosomes were characterized with dynamic light scattering (DLS) and Western blot and analysed with Illumina whole genome microarray gene expression. Results: An average size of 50-80 nm in diameter with no difference between treatment groups was found. Analysis of the mRNA content revealed 623 transcripts in the control group, 691 in the TGF-beta2-treated group and 362 in the PDGF-BB-treated group. 235 transcripts were common for all three groups. Conclusion: We conclude that there is a difference in mRNA content between exosomes derived from cultured cardiomyocytes stimulated with growth factors. We also conclude that all exosomes contain a basic package consisting of ribosomal transcripts and mRNAs coding for proteins with functions within the energy supply system. To study if the transcriptional content in exosomes derived from untreated and growth factor-treated cultured cardiomyocytes (HL-1) differ, and if so, can this difference be explained, 4 control (untreated) exosome samples, 4 TFG-beta2-treated cardiomyocyte-derived exosome samples and 4 PDGF-BB-treated cardiomyocyte-derived exosomes were studied.

2013-06-20 | E-GEOD-40503 | biostudies-arrayexpress

PLK inhibitors identified by high content phenotypic screening promote maturation of human iPSC-derived cardiomyocytes

Project description:PLK inhibitors identified by high content phenotypic screening promote maturation of human iPSC-derived cardiomyocytes

| PRJNA812415 | ENA

PLK inhibitors identified by high content phenotypic screening promote maturation of human iPSC-derived cardiomyocytes

Project description:We performed RNA-Seq analysis of human pluripotent stem cells derived cardiomyocytes (hPSC-CMs) which were treated with Centrinone or Volasertib for 14 days to investigate the moleclular mechanism of inhibiting L-type calcium channel (LTCC) to promote cardiomyocyte proliferation.

2022-03-06 | GSE197835 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data